Intermittent hemodiafiltration in acute renal failure in critically ill patients

Area of Science:

• Nephrology
• Intensive Care Medicine
• Renal Replacement Therapy

Background:

• Acute renal failure (ARF) management often requires renal replacement therapy.
• Intermittent hemodialysis (IHD) and intermittent on-line predilution hemodiafiltration (IHDF) are common treatment modalities.
• Comparing the efficacy and safety of IHDF versus IHD is crucial for optimizing patient care.

Purpose of the Study:

• To compare the effects of daily IHDF and IHD on laboratory parameters.
• To evaluate the impact of IHDF versus IHD on multiple organ dysfunction score (MODS).
• To assess treatment-related outcomes including days free of ARF treatment and hospital mortality.

Main Methods:

• A prospective, randomized, non-blinded study was conducted in a tertiary-care hospital's medical-surgical intensive care unit.
• Thirty-nine patients with acute renal failure were randomized to receive either daily IHDF or IHD for up to 30 days.
• Laboratory parameters, MODS, survival, and complications were recorded.

Main Results:

• Both IHDF and IHD demonstrated equivalent control of azotemia, acidosis, and calcium-phosphate balance.
• The urea reduction ratio and changes in serum creatinine, calcium, phosphate, and bicarbonate were similar between groups.
• Patients undergoing IHDF experienced fewer days free of acute renal failure treatment (4.8 days) compared to IHD (10.3 days).

Conclusions:

• Daily IHDF and IHD provide comparable control over key laboratory parameters in acute renal failure.
• No treatment-specific complications were observed for IHDF.
• Despite similar efficacy in biochemical control, IHDF was associated with a shorter duration of freedom from acute renal failure treatment.